• LAST PRICE
    7.4800
  • TODAY'S CHANGE (%)
    Trending Up0.0200 (0.2681%)
  • Bid / Lots
    7.5000/ 10
  • Ask / Lots
    7.8500/ 6
  • Open / Previous Close
    7.5100 / 7.4600
  • Day Range
    Low 7.4500
    High 7.6150
  • 52 Week Range
    Low 5.0100
    High 12.7500
  • Volume
    231,375
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 7.44
TimeVolumeCMPS
09:32 ET70547.5
09:34 ET7167.5
09:36 ET6737.45
09:38 ET3007.45
09:39 ET20007.5171
09:41 ET2507.535
09:43 ET1007.535
09:48 ET5007.55
09:50 ET4007.58
09:52 ET12297.575
09:54 ET14667.59
09:56 ET22067.5696
09:57 ET13057.57
09:59 ET1007.5999
10:01 ET2207.5666
10:03 ET4307.57
10:06 ET2337.5714
10:08 ET12867.53
10:10 ET19637.45
10:14 ET1007.47
10:17 ET2007.5161
10:19 ET1337.5153
10:21 ET5007.495
10:24 ET1007.47
10:26 ET34187.505
10:28 ET6007.5087
10:30 ET9027.5
10:32 ET7737.49
10:33 ET5007.5
10:37 ET4207.48
10:39 ET38977.48
10:42 ET2007.47
10:44 ET1007.46
10:46 ET11677.4636
10:48 ET5007.48
10:50 ET6607.52
10:51 ET2007.52
10:53 ET6007.505
10:57 ET15807.53
11:00 ET3057.525
11:02 ET1007.525
11:04 ET1007.525
11:06 ET1007.525
11:09 ET1007.525
11:11 ET2007.545
11:13 ET3007.56
11:15 ET2087.5518
11:18 ET23007.5684
11:20 ET10007.53
11:22 ET1007.53
11:24 ET7997.5387
11:26 ET8337.54
11:27 ET2007.525
11:29 ET3507.525
11:31 ET2007.51
11:33 ET1007.515
11:36 ET1007.5233
11:38 ET1427.51
11:42 ET4887.51
11:44 ET42637.49
11:45 ET15007.52
11:47 ET61957.565
11:49 ET1507.554
11:51 ET38987.5001
11:54 ET59227.53
11:58 ET1007.525
12:02 ET2007.51
12:05 ET4007.51
12:07 ET3507.525
12:09 ET1007.51
12:14 ET5007.51
12:16 ET16137.495
12:18 ET1007.485
12:20 ET9057.485
12:21 ET11187.51
12:25 ET81147.515
12:30 ET1407.49
12:32 ET111807.515
12:34 ET1307.49
12:36 ET3007.515
12:38 ET2457.536
12:41 ET31007.52
12:43 ET3007.52
12:45 ET7827.53
12:48 ET24387.51
12:50 ET4007.51
12:54 ET3507.5179
12:56 ET54747.5
12:59 ET2077.48
01:01 ET9007.49
01:03 ET1007.48
01:08 ET1007.4601
01:14 ET2007.49
01:17 ET2007.49
01:21 ET3007.46
01:24 ET86827.48
01:26 ET9007.49
01:30 ET3007.47
01:32 ET2007.49
01:33 ET8957.48
01:35 ET41897.51
01:37 ET28507.51
01:39 ET3007.51
01:44 ET5007.5
01:46 ET17727.5
01:48 ET4007.48
01:50 ET1007.47
01:51 ET1007.47
01:53 ET1007.48
01:55 ET12057.49
01:57 ET12007.5
02:00 ET2007.49
02:02 ET5507.49
02:06 ET5007.48
02:09 ET4007.46
02:13 ET1007.465
02:15 ET11007.485
02:18 ET7007.51
02:20 ET2617.48
02:24 ET1007.51
02:26 ET1007.5
02:27 ET6557.5
02:31 ET3007.4996
02:33 ET5607.505
02:36 ET2007.49
02:38 ET2007.5
02:40 ET4007.5
02:42 ET6007.495
02:45 ET4417.4835
02:47 ET1007.5
02:58 ET5007.51
03:00 ET4007.5
03:02 ET5007.51
03:03 ET4007.515
03:05 ET1957.5266
03:07 ET25307.54
03:09 ET2007.54
03:14 ET5007.53
03:16 ET1007.53
03:18 ET2007.53
03:20 ET3007.51
03:23 ET3007.51
03:27 ET2007.525
03:30 ET5967.52
03:34 ET29857.5329
03:36 ET2007.52
03:38 ET43357.515
03:43 ET3007.5
03:45 ET31067.515
03:48 ET5007.5
03:50 ET34237.49
03:52 ET50607.52
03:54 ET6287.51
03:56 ET2007.51
03:57 ET6487.51
03:59 ET58367.48
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCMPS
Compass Pathways PLC
511.5M
-3.2x
---
United StatesLXEO
Lexeo Therapeutics Inc
509.3M
-5.7x
---
United StatesOLMA
Olema Pharmaceuticals Inc
506.8M
-4.5x
---
United StatesALT
Altimmune Inc
519.7M
-4.6x
---
United StatesMREO
Mereo BioPharma Group PLC
413.8M
-11.1x
---
United StatesALLO
Allogene Therapeutics Inc
525.1M
-1.4x
---
As of 2024-05-26

Company Information

Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in the development of psilocybin treatment, in which its investigational COMP360 psilocybin is administered in conjunction with psychological support, COMP360 psilocybin treatment. COMP360 is its proprietary psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.

Contact Information

Headquarters
3Rd Floor, 1 Ashley RoadALTRINCHAM, United Kingdom WA14 2DT
Phone
---
Fax
---

Executives

Interim Independent Chairman of the Board
David Norton
Chief Executive Officer, Executive Director
Kabir Nath
Chief Financial Officer, Principal Accounting Officer
Teri Loxam
General Counsel, Chief Legal Officer
Matthew Owens
Chief Medical Officer
Guy Goodwin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$511.5M
Revenue (TTM)
$0.00
Shares Outstanding
68.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.31
EPS
$-2.37
Book Value
$3.64
P/E Ratio
-3.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.